LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Mouse Model With Modified Tumor Suppressor Gene

By Biotechdaily staff writers
Posted on 03 Jan 2005
Researchers have introduced mutations in the p53 tumor suppressor gene to a line of mice so that the animals mimic humans suffering from the rare Li-Fraumeni Syndrome (LFS), which predisposes affected individuals to develop multiple cancers.

In order to create LFS in mice, investigators at the Massachusetts Institute of Technology (Boston, USA) modified the p53 gene rather than completely disable it. They reported in the December 17, 2004, issue of Cell that animals with two different p53 mutations developed a variety of cancers that were not seen in either normal control animals or in mice lacking p53.

"The LFS mouse strains, which have been many years in the making, will be extremely valuable in understanding how the common mutations in p53 contribute to tumor formation,” said senior author Dr. Tyler Jacks, professor of biology at the Massachusetts Institute of Technology. "We expect these strains will also help us determine how to specifically treat p53 mutant tumors.”



Related Links:
Massachusetts Institute of Technology

Gold Member
Quantitative POC Immunoassay Analyzer
EASY READER+
New
Gold Member
STI Test
Vivalytic MG, MH, UP/UU
New
Food Allergy Screening ELISA Kit
Allerquant 14G B ELISA
New
Japanese Encephalitis Test
Japanese Encephalitis Virus Real Time PCR Kit

Latest BioResearch News

Study Identifies Protein Changes Driving Immunotherapy Resistance in Multiple Myeloma
03 Jan 2005  |   BioResearch

Genetic Analysis Identifies BRCA-Linked Risks Across Multiple Cancers
03 Jan 2005  |   BioResearch

Study Identifies Hidden B-Cell Mutations in Autoimmune Disease
03 Jan 2005  |   BioResearch